A case of a hemodialysis patient with secondary hyperparathyroidism who was resistant to etelcalcetide treatment but not to cinacalcet hydrochloride

Although both cinacalcet and etelcalcetide are calcimimetics that directly inhibit parathyroid hormone (PTH) secretion by activating the calcium (Ca)-sensing receptor (CaSR), their binding sites are different. We report a first case of a hemodialysis (HD) patient with secondary hyperparathyroidism (...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakamura, Hironori, Tokumoto, Masanori, Anayama, Mariko, Kurihara, Shigekazu, Makino, Yasushi, Tamura, Katsuhiko, Nagasawa, Masaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9061916/
https://www.ncbi.nlm.nih.gov/pubmed/34787825
http://dx.doi.org/10.1007/s13730-021-00664-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9061916/
https://www.ncbi.nlm.nih.gov/pubmed/34787825
http://dx.doi.org/10.1007/s13730-021-00664-0

Ejemplares similares